Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Clinical trial NCT01882361 · COMPLETED

Trial details

NCT number: NCT01882361
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Opiate Dependence Human Immunodeficiency Virus

Start date: 2013-06-01
Primary completion: 2020-07-31
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.